alternate: fulvestrant and/or anastrozole in er her2- postmenopausal breast cancer
Published 4 years ago • 2.3K plays • Length 6:23Download video MP4
Download video MP3
Similar videos
-
4:06
serena-2: camizestrant vs fulvestrant in post-menopausal women with advanced er /her- breast cancer
-
3:44
alternate: neoadjuvant endocrine treatment in er /her2- breast cancer
-
0:59
treatments for hr postmenopausal breast cancer
-
5:02
samuraciclib in combination with fulvestrant in patients with advanced hr /her2- breast cancer
-
10:15
monaleesa-3 os results: fulvestrant/ribociclib in postmenopausal hr /her2- advanced breast cancer
-
1:02
phase iii trial of pf-07220060 and fulvestrant in hr /her2- breast cancer
-
1:44
precoopera: giredestrant versus anastrozole in er /her2- early breast cancer
-
2:59
talent: neoadjuvant t-dxd with or without anastrozole for her2-low, hr early stage breast cancer
-
5:28
capitello-291: capivasertib fulvestrant for ai-resistant hr /her2- advanced breast cancer
-
1:49
phase ib data capitello-292: capivasertib palbociclib fulvestrant in hr /her2- breast cancer
-
2:49
neratinib, trastuzumab fulvestrant for her2-mutant, hr , metastatic breast cancer
-
6:25
combination of anastrozole and fulvestrant in metastatic breast cancer
-
5:50
anastrozole and fulvestrant in hormone receptor-positive breast cancer
-
6:55
fulvestrant versus anastrozole in patients with advanced breast cancer
-
3:04
12-year results of anastrozole vs tamoxifen for breast cancer prevention
-
10:31
fulvestrant and anastrozole in combination: fact or fiction?
-
10:15
copanlisib and fulvestrant with abemaciclib in her-, er breast cancer
-
5:50
anastrazole and fulvestrant in hormone receptor-positive breast cancer
-
1:21
qol in monaleesa-2, 3, and 7